PRIMARY STUDY
Endocannabinod Signal Dysregulation In Autism Spectrum Disorders: A Correlation Link Between Inflammatory State And Neuro-Immune Alterations
Key Findings: These new findings offer a novel perspective in autism research and indicate that the EC system could represent a novel target option for autism pharmacotherapy.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Italy, United States
Year of Pub: 2017
Cannabinoids Studied: Anandamide (AEA), 2-Arachidonoyl Glycerol (2-AG)
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2
Citation: Brigida AL, et al. Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations. Int J Mol Sci. 2017; 18:(unknown pages). doi: 10.3390/ijms18071425
Authors: Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D
